G. Lissovoy

发表

Big data meets the electronic medical record: a commentary on "identifying patients at increased risk for unplanned readmission".

G. Lissovoy, 2013 .

Economic issues in the treatment and prevention of deep vein thrombosis from a managed care perspective.

G. Lissovoy, 2001 .

Cost-effectiveness of Treating Chronic Anemia with Epoetin Alfa among Hemodialysis Patients in the U

C. Hollenbeak, W. McClellan, S. Mohan, 2012 .

The impact of end-stage renal disease transfusion demand on blood utilization and blood supply in the United States

C. Hollenbeak, B. Custer, H. Naci, 2012 .

Measuring the burden of illness for end-stage renal disease: some heavy lifting required.

G. Lissovoy, 2007 .

The implantable cardiac defibrillator: is the glass half empty or half full?

G. Lissovoy, 2007 .

Patient Selection in the Medicare End-Stage Renal Disease Program

G. Lissovoy, 1988 .

Building a Clinical Research Network in Trauma Orthopaedics: The Major Extremity Trauma Research Consortium (METRC)

Patrick M. Osborn, Christopher S. Smith, Kristin R. Archer, 2016, Journal of orthopaedic trauma.

Economic analysis of unrelated allogeneic bone marrow transplantation: results from the randomized clinical trial of T-cell depletion vs unmanipulated grafts for the prevention of graft-versus-host disease

D. Weisdorf, M. Ewell, S. Yanovich, 2005, Bone Marrow Transplantation.

Hospital costs for treatment of acute heart failure: economic analysis of the REVIVE II study

J. Mullahy, A. Durtschi, R. Sterz, 2010, The European Journal of Health Economics.

Economic modeling of new stent platforms to evaluate cost effectiveness: analysis of the TAXUS Liberté versus TAXUS express stents.

A. Kansal, S. Amorosi, M. Turco, 2012, Journal of interventional cardiology.

A Taxonomy and Economic Consequences of Nursing Home Falls

S. Studenski, B. Resnick, M. Rupnow, 2006, Drugs & aging.

Cost-effectiveness of long-term intrathecal morphine therapy for pain associated with failed back surgery syndrome.

Ruth E. Brown, S. Hassenbusch, G. de Lissovoy, 1997, Clinical therapeutics.

The production of dialysis by for-profit versus not-for-profit freestanding renal dialysis facilities.

N. Powe, P. Whelton, G. Anderson, 1994, Health services research.

Medicare payment policy and recombinant erythropoietin prescribing for dialysis patients.

N. Powe, P. Whelton, G. de Lissovoy, 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Observation unit treatment of heart failure with nesiritide: results from the proaction trial.

G. de Lissovoy, W. Peacock, M. Klapholz, 2005, The Journal of emergency medicine.

Cost-effectiveness of the implantable cardioverter-defibrillator.

G. de Lissovoy, T. Guarnieri, G. Lissovoy, 1993, Progress in cardiovascular diseases.

A prospective study of the cost-utility of the multichannel cochlear implant.

G. de Lissovoy, J. Niparko, G. Lissovoy, 1999, Archives of otolaryngology--head & neck surgery.

Razing a Tower of Babel: a taxonomy for managed care and health insurance plans.

G. de Lissovoy, J. Weiner, G. Lissovoy, 1993, Journal of health politics, policy and law.

Strategic activity and financial performance of U.S. rural hospitals: a national study, 1983 to 1988.

G. Lissovoy, A. Jones, Laura L. Morlock, 1994, The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association.

The cost of a preventable disease: estimated U.S. national medical expenditures for congenital syphilis, 1990.

G. de Lissovoy, D. Celentano, K. Nelson, 1995, Public health reports.

Cost for inpatient care of venous thrombosis: a trial of enoxaparin vs standard heparin.

G. de Lissovoy, R. Yusen, S. Sorensen, 2000, Archives of internal medicine.

Early dosing practices and effectiveness of recombinant human erythropoietin.

N. Powe, P. Whelton, G. de Lissovoy, 1993, Kidney international.